ConvaTec Regulatory News (CTEC)

ConvaTec Director Declaration

Reading, United Kingdom (3 April 2020)

ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Dr Ros Rivaz, a Non-Executive Director of the Company, has accepted a nomination to be appointed to the Board of Aperam S.A., as a Non-Executive Director, subject to a shareholder vote on 5 May 2020.

This announcement is made in accordance with Listing Rule 9.6.14R.

Enquiries

Analysts and Investors

Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625

ir@convatec.com

Media

Buchanan: Charles Ryland / Chris Lane / Vicky Haynes +44 (0)207 466 5000

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.